Lund center for Stem Cell Biology and Cell Therapy is one of six Swedish strategic centers of excellence in life sciences, supported by the Swedish Foundation for Strategic Research. Established in January 2003, the center focuses on stem cell and developmental biology of the central nervous and blood systems, and development of stem cell and cell replacement therapies in these organ systems as well as research in non-mammalian model systems.
Stem Cell Center and StemTherapy researchers Henrik Ahlenius and Cristian Bellodi have received project grants, 6 000 000 SEK, from the Swedish Research Council's distribution of funding for medical research. Congratulations!
Honghze Li, PhD is the first author of a recent study from the Scheding lab, Lund Stem Cell Center on primary mesenchymal stroma cells (MSC). By utilizing comparative gene expression analysis, Li et al identified novel markers for bone marrow MSC and they were able to define the phenotype of primary MSC (lin-, CD45-, CD271+/CD140alow/-). This key finding will lead to a better characterization of this important cell type in normal and diseased human bone marrow.
It is time for the next PI Talk! Johan Jakobsson from the Lab of Molecular Neurogenetics will present his research entitled: Exploring the function of microRNAs in the brain. Time and place: 5th of November 2014, 16.00, in GK-salen. Snacks and soft drinks will be served from 15.45 outside GK-salen. Johan’s research is currently focused on examining and understanding the role of microRNAs in the processes of gene regulation during neurodegenerative diseases in the brain, and how microRNAs influences neurodegenerative diseases, psychiatric disorders and brain tumors.
A post-doctoral research position is available in the Glioma Cell Therapy Group lead by Johan Bengzon. The aim of our program is to develop a clinical therapy of invasive brain tumors using tumor-tropic cellular vectors for the delivery of immunostimulatory and tumoricidal substances. Using models of glioblastoma, the most common and aggressive form of primary brain tumour, we currently explore the potential of migratory cellular vector systems that effectively home to tumour microsatellites and eliminate these by delivering antitumor agents. The project is also designed to identify novel target for the development of improved pharmacological treatment of GBM.
Lund Stem Cell Center presents: International Young Investigator Symposium 2014 - Technologies in Stem Cell Research! The Lund Stem Cell Center is pleased to announce the first annual International Young Investigator Symposium consisting of three first authors of key publications in the past year. While senior authors often get the chance to promote high impact work we feel that the scientists behind the actual experiments deserve more exposure. Our theme for 2014 is Technologies in Stem Cell Research and our vision is to stimulate scientific exchange and facilitate future collaborations.